Status:

COMPLETED

Activity and Metformin Intervention in Obese Adolescents

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Obesity

Type 2 Diabetes

Eligibility:

All Genders

10-16 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess the sustainability of a two-year intervention aimed at improving body mass index (BMI) and metabolic and vascular health in obese youth. The study will compare l...

Detailed Description

This study will assess the sustainability of a two-year intervention and the degree of improvement in body mass index (BMI) and reduction in risk factors for type 2 diabetes and diabetes related cardi...

Eligibility Criteria

Inclusion

  • Obese adolescents defined as BMI greater than the 95th percentile for age and gender
  • Metformin naive subjects

Exclusion

  • Elevated fasting plasma glucose ≥ 6.0 mmol/L
  • 2 hour plasma glucose ≥ 11.1 mmol/L after a standard glucose load
  • A1C \> 6.0%
  • Medication other than "over the counter" drugs, oral contraceptive pill or thyroid hormone replacement
  • Smoking
  • Pregnancy
  • Renal insufficiency (serum creatinine \> the upper limit of normal)
  • Hepatic dysfunction (\> 1.5 times the upper limit of normal for AST and ALT)
  • Latex Allergy
  • Hypersensitivity to metformin or its ingredients
  • Breast feeding
  • Subjects with a history of lactic acidosis
  • Abnormal creatinine clearance
  • HIV, HBV, and HCV infections
  • Drug and alcohol abuse
  • Severe mental disorders
  • Subjects who are planning radiologic exams involving in i.v. injection of iodinated contract materials
  • Participation in another clinical trial
  • Significant history or presence of cardiovascular, pulmonary, gastrointestinal, immunologic, endocrine, neurologic disorders
  • Malignant diseases
  • Previous exposure to any pharmaceutical antidiabetic agent

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2012

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00934570

Start Date

April 1 2009

End Date

May 1 2012

Last Update

October 4 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Hospital, London Health Sciences Centre

London, Ontario, Canada, N6A 5W9